A legislator’s commentary about Medicaid expansion doesn’t address the real struggles people face.
medicaid
Posted inOp-eds, Opinion
Commentary: MaineCare expansion would force bad results for Mainers on the margins
Approving the expansion at the ballot box would force some Mainers onto Medicaid insurance.
advertisement
Posted inMaine Voices, Op-eds, Opinion
Maine Voices: Blaming police for failures of mental health system is misplaced
The fault lies with the failure of our mental health system to adequately treat the seriously mentally ill.
Posted inEditorials, Opinion
Our View: Care shortage puts women and infants at risk
Proposals to eliminate the ACA and gut Medicaid undercut innovative efforts to meet critical medical needs.
Posted inOp-eds, Opinion
Commentary: Expanding Medicaid will help Maine hospitals, health centers and the economy
A ‘yes’ vote on Question 2 this Nov. 7 is a vote for jobs, for care and for facts over fear.
Posted inLocal & State, News, Politics
State alters wording of ballot questions on Medicaid expansion, York casino
Republicans praise the Medicaid referendum change because it may have political benefits, and a phrase is cut from the casino language because it could be viewed as creating bias.
Posted inBill Nemitz, Local & State, News, Opinion
Bill Nemitz: Whine about insurance? For many Mainers it’s really about surviving.
Republicans use their dictionaries to once again demonize the poor.
Posted inLocal & State, News, Politics
Republican group asks to strike ‘insurance’ from Medicaid expansion ballot wording
Rick Bennett and a group of Republican lawmakers want the program to be described as ‘taxpayer-funded health benefits’ or ‘government-funded health benefits.’
Posted inLocal & State, News, Politics
Republicans organize to raise concerns about Medicaid expansion in Maine
Former state Senate President Rick Bennett will lead a news conference Tuesday that could be a prelude to a formal campaign against Question 2 on the Nov. 7 ballot.
Posted inBusiness, Health, News
Maine getting $950,000 under settlement with EpiPen maker
Mylan, the drug’s manufacturer, has settled with the federal Department of Justice over allegations of overcharging Medicaid for its emergency allergy medication.